Calcium Gluconate Dosing for Hypocalcemia
Recommended Dosing by Patient Population
For pediatric patients with acute symptomatic hypocalcemia, administer 60 mg/kg of calcium gluconate intravenously, infused over 30-60 minutes. 1
Pediatric Dosing (Including Neonates)
- Standard dose: 60 mg/kg IV infused over 30-60 minutes for mild to moderate hypocalcemia 1
- Emergency/cardiac arrest: Administer by slow IV push with close heart rate monitoring, repeating as necessary for desired clinical effect 1
- Neonates and infants: The same 60 mg/kg dose applies, though asymptomatic cases may be managed with 40-80 mg/kg/day of elemental calcium for maintenance 2
- Acute symptomatic treatment in neonates: 10-20 mg/kg of elemental calcium (1-2 mL/kg of 10% calcium gluconate) given as slow IV infusion for tetany or hypocalcemic seizures 2
Adult Dosing
- Mild hypocalcemia (ionized calcium 1.0-1.12 mmol/L): 1-2 g IV calcium gluconate infused at 1 g/hour 3, 4
- Moderate to severe hypocalcemia (ionized calcium <1.0 mmol/L): 4 g IV calcium gluconate infused at 1 g/hour 4, 5
- The 4 g regimen successfully normalized calcium in 95% of critically ill trauma patients with moderate to severe hypocalcemia 5
Special Clinical Situations
- Calcium channel blocker toxicity: Initial bolus of 0.6 mL/kg of 10% calcium gluconate (30-60 mL or 3-6 grams in adults) IV over 5-10 minutes, followed by continuous infusion at 0.6-1.2 mL/kg/hour 1, 6
- Hyperkalemia (cardiac stabilization): 15-30 mL of 10% calcium gluconate IV over 2-5 minutes 6
- Hypermagnesemia with cardiac arrest: 15-30 mL of 10% calcium gluconate IV over 2-5 minutes 6
Administration Guidelines
Route and Rate
- Administer intravenously only via a secure IV line, preferably through a central venous catheter to minimize extravasation risk 1, 6, 7
- Infusion rate: For non-emergent situations, infuse at 1 g/hour or over 30-60 minutes 1, 3, 4
- Avoid rapid infusion to prevent cardiac arrhythmias and symptomatic bradycardia 1
Dilution
- Dilute with 5% dextrose or normal saline before administration 7
- Do not mix with fluids containing phosphate or bicarbonate, as precipitation will occur 7
Critical Monitoring Requirements
Cardiac Monitoring
- Continuous ECG monitoring is essential during administration, particularly in patients receiving cardiac glycosides 1, 6
- Stop infusion immediately if symptomatic bradycardia occurs or heart rate decreases by 10 beats per minute 1
Laboratory Monitoring
- Intermittent infusions: Measure serum calcium every 4-6 hours 7
- Continuous infusions: Measure serum calcium every 1-4 hours 7
- Post-infusion assessment: Check ionized calcium approximately 10 hours after completion of infusion to ensure equilibration and assess efficacy 4
Important Safety Considerations
Extravasation Risk
- Calcium gluconate is strongly preferred over calcium chloride for peripheral IV administration due to significantly less tissue irritation 1, 6
- Central venous access is preferred; extravasation through peripheral lines may cause severe skin and soft tissue injury, calcinosis cutis, tissue necrosis, ulceration, and secondary infection 1, 6, 7
- If extravasation occurs or calcinosis cutis develops, immediately discontinue administration at that site 7
Drug Interactions
- Cardiac glycosides: Synergistic arrhythmias may occur; if concomitant therapy is necessary, give calcium slowly in small amounts with close ECG monitoring 7
- Calcium channel blockers: Calcium administration may reduce the therapeutic response to these medications 7
- Ceftriaxone: Absolutely contraindicated in neonates ≤28 days old due to risk of fatal intravascular precipitates 7
Special Populations
- Renal impairment: Initiate at the lower end of the dosage range and monitor serum calcium every 4 hours 7
- Elderly patients: Start at the low end of the dosage range 7
Clinical Pearls
- About half of the administered calcium dose is retained in the exchangeable calcium space, with higher doses (4 g vs 2 g) resulting in proportionally more elemental calcium retention 4
- Most hypocalcemic critically ill patients normalize calcium within 4 days of admission, regardless of supplementation 8
- Failure to normalize calcium by day 4 in severely hypocalcemic patients may be associated with doubled mortality (38% vs 19%) 8
- Adjusted calcium <2.2 mmol/L has only 78% sensitivity and 63% specificity for predicting ionized calcium <1.1 mmol/L; ionized calcium measurement is preferred in critical care settings 8
- Low magnesium, sodium, and albumin are independently associated with hypocalcemia; correct hypomagnesemia concurrently for optimal response 8